Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Lenz Therapeutics, Inc.

NASDAQ: LENZ · Life Sciences · 3 alerts · CIK 1815776

Share price
$3.82Close, Nov 16
Market cap
$120M
Shares outstanding
31.42MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Lenz Therapeutics, Inc. filings on SEC EDGAR ↗

5:44 PM ET Form 4
Insider Selling

Lenz Therapeutics 10% Owner Ra Capital Management L.P. Sells $9.13M of Stock

Ra Capital Management L.P., 10% Owner, sold 2,718,684 shares of Lenz Therapeutics, Inc. at $3.36 a share, worth $9.13M in total on Oct 29, 2026. Shares held after the trade: 57,559 (-65.1%).

Value
$9.13M
Shares
2,718,684
Average price
$3.36
Role
10% Owner
Holding change
-65.1%
Trade date
Oct 29, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.